基于DCE-MRI和DWI的瘤内异质性定量评估用于乳腺癌亚型表征
该回顾性研究纳入248例浸润性乳腺癌患者,利用DCE-MRI的动力学异质性和DWI的ADC异质性定量指标,分析其与分子亚型的关联。结果显示TNBC的动力学和ADC异质性均较高,HER2富集型动力学异质性较高,提示MRI定量异质性可反映肿瘤生物学特征。
要点
- 动力学异质性升高与HER2富集型和三阴性乳腺癌相关。
- ADC异质性升高与三阴性乳腺癌相关。
- 侵袭性亚型表现出更高的瘤内MRI异质性。
关键影像表现/征象
- TNBC表现出更高的动力学异质性和ADC异质性。
- HER2富集型相比Luminal亚型表现出更高的动力学异质性。
诊断标准与关键数值
- 动力学异质性定义为肿瘤内延迟 washout、平台和持续强化像素比例异质性的度量。
- ADC异质性计算公式为(ADCmax-ADCmin)/ADCmean。
- 各亚型间动力学异质性差异显著(p<0.001),ADC异质性差异显著(p=0.023)。
- 多变量线性分析显示HER2富集型(p<0.001)和TNBC(p<0.001)与更高动力学异质性显著相关。
- TNBC(p=0.042)与更高ADC异质性显著相关。
临床应用与阅片要点
- 阅片时可关注DCE-MRI动力学异质性和ADC异质性,辅助提示侵袭性亚型如TNBC或HER2富集型。
- 动力学异质性基于CAD系统定量,需注意不同软件算法可能影响结果。
- ADC异质性依赖ROI勾画,应规范测量以减少变异。
局限性
- 回顾性单中心设计,可能存在选择偏倚。
- 样本来自单一时间段,外推性需验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate whether intratumoral heterogeneity, assessed via dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI), reflects the molecular subtypes of invasive breast cancers.
MATERIAL AND METHODS: We retrospectively evaluated data from 248 consecutive women (mean age ± standard deviation, 54.6 ± 12.2 years) with invasive breast cancer who underwent preoperative DCE-MRI and DWI between 2019 and 2020. To evaluate intratumoral heterogeneity, kinetic heterogeneity (a measure of heterogeneity in the proportions of tumor pixels with delayed washout, plateau, and persistent components within a tumor) was assessed with DCE-MRI using a commercially available computer-aided diagnosis system. Apparent diffusion coefficients (ADCs) were obtained using a region-of-interest technique, and ADC heterogeneity was calculated using the following formula: (ADCmax-ADCmin)/ADCmean. Possible associations between imaging-based heterogeneity values and breast cancer subtypes were analyzed.
RESULTS: Of the 248 invasive breast cancers, 61 (24.6%) were classified as luminal A, 130 (52.4%) as luminal B, 25 (10.1%) as HER2-enriched, and 32 (12.9%) as triple-negative breast cancer (TNBC). There were significant differences in the kinetic and ADC heterogeneity values among tumor subtypes (p < 0.001 and p = 0.023, respectively). The TNBC showed higher kinetic and ADC heterogeneity values, whereas the HER2-enriched subtype showed higher kinetic heterogeneity values compared to the luminal subtypes. Multivariate linear analysis showed that the HER2-enriched (p < 0.001) and TNBC subtypes (p < 0.001) were significantly associated with higher kinetic heterogeneity values. The TNBC subtype (p = 0.042) was also significantly associated with higher ADC heterogeneity values.
CONCLUSIONS: Quantitative assessments of heterogeneity in enhancement kinetics and ADC values may provide biological clues regarding the molecular subtypes of breast cancer.
KEY POINTS: • Higher kinetic heterogeneity was associated with HER2-enriched and triple-negative breast cancer. • Higher ADC heterogeneity was associated with triple-negative breast cancer. • Aggressive breast cancer subtypes exhibited higher intratumoral heterogeneity based on MRI.
引用
- Kim JJ, Kim JY, Suh HB, et al. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging. Eur Radiol. 2021. PMID: 34345946. doi:10.1007/s00330-021-08166-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。